Mexico Vaccines Market Size & Outlook, 2025-2033

Mexico Vaccines Market Insights

As per Reed Intelligence insights, the Mexico Vaccines Market stood at USD 1491.68 Million in 2024 and is anticipated to grow to USD 2921.05 Million by 2033.
The Mexico market is expected to advance at a CAGR of 7.67% from 2025 through 2033.
In 2024, Monovalent accounted for the highest share of the By Type market size.
During the forecast period, Monovalent is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings

As of 2024, Mexico held 2.21% of the global Vaccines Market size.
By 2033, United States is anticipated to capture the largest share of the global Vaccines Market.
In LATAM, Brazil is expected to lead the regional Vaccines Market size by 2033.
Mexico will remain the fastest-growing market in LATAM, reaching USD 2900.87 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 1491.68 Million
Market Size In 2033	USD 2921.05 Million
Largest segment	Monovalent
Units	Revenue in USD Million
CAGR	7.67% (2025-2033)
Segmnetation Covered
By Type	Monovalent Multivalent
By Route of Administration	Oral Parenteral Nasal
By Disease Indication	Viral Bacterial
By Age Group	Pediatric Adult
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Mexico Vaccines Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Monovalent	XX.x	XX.x	XX.x	878.3	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Multivalent	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Mexico Vaccines Market By Route of Administration 2025-2033 (USD Million)

By Route of Administration	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oral	XX.x	XX.x	XX.x	676.33	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Parenteral	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nasal	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Mexico Vaccines Market By Disease Indication 2025-2033 (USD Million)

By Disease Indication	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Viral	XX.x	XX.x	XX.x	954.82	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Bacterial	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Mexico Vaccines Market By Age Group 2025-2033 (USD Million)

By Age Group	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pediatric	XX.x	XX.x	XX.x	880.54	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Adult	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.